Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O4KY
|
||||
Former ID |
DNC012855
|
||||
Drug Name |
Tyr-Pro-Phe-Phe-OCH3
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529480] | ||
Structure |
Download2D MOL |
||||
Formula |
C33H38N4O6
|
||||
Canonical SMILES |
COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3CCCN<br />3C(=O)C(CC4=CC=C(C=C4)O)N
|
||||
InChI |
1S/C33H38N4O6/c1-43-33(42)28(21-23-11-6-3-7-12-23)36-30(39)27(20-22-9-4-2-5-10-22)35-31(40)29-13-8-18-37(29)32(41)26(34)19-24-14-16-25(38)17-15-24/h2-7,9-12,14-17,26-29,38H,8,13,18-21,34H2,1H3,(H,35,40)(H,36,39)/t26-,27-,28-,29-/m0/s1
|
||||
InChIKey |
YYNCXEIEPLRPCR-DZUOILHNSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [529480] | |
Delta-type opioid receptor | Target Info | Inhibitor | [529480] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.